Clinical Evaluation of Two Daily Disposable Contact Lenses

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

279 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-06-30

Study Completion Date

2013-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study is to compare the ease of removing two daily disposable soft contact lenses off the eye.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluation of Delefilcon A and Senofilcon A Daily Disposable Toric Soft Contact Lenses Over One Week of Wear

NCT06749496

Astigmatism

COMPLETED NA

Clinical Evaluation of Delefilcon A and Verofilcon A Daily Disposable Toric Soft Contact Lenses Over One Week of Wear

NCT05502289

Ocular Physiology

COMPLETED NA

Clinical Evaluation of an Investigational Soft Contact Lens

NCT01254747

Myopia

COMPLETED NA

A Comparison of Two Daily Disposable Contact Lenses.

NCT00721500

Refractive Error Myopia

COMPLETED NA

A Comparison of Two Daily Disposable Soft Contact Lenses

NCT02427477

Visual Acuity

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Refractive Error

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

delefilcon A

Spherical daily disposable soft contact lens

Group Type ACTIVE_COMPARATOR

delefilcon A

Intervention Type DEVICE

Daily disposable soft contact lens to be worn at least 8 hours daily

narafilcon A

Spherical daily disposable soft contact lens Class 1 UV blocking

Group Type EXPERIMENTAL

narafilcon A

Intervention Type DEVICE

Daily disposable contact lens to be worn at least 8 hours daily

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

delefilcon A

Daily disposable soft contact lens to be worn at least 8 hours daily

Intervention Type DEVICE

narafilcon A

Daily disposable contact lens to be worn at least 8 hours daily

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

DAILIES Total 1 1-Day ACUVUE TruEye

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. The subject must be between 18 and 45 years of age (inclusive)with no presbyopic add.
2. The subject must read, understand, and sign the STATEMENT OF INFORMED CONSENT and receive a fully executed copy of the form. This should be recorded on the Case Report Form (CRF).
3. The subject must be willing to wear the study lenses for at least 8 hours per day, at least 6 days between visits.
4. The subject must be a current successful spherical soft contact lens wearer in both eyes.
5. The subject must appear willing and able to adhere to the instructions set forth in this clinical protocol.
6. The subject's subjective refraction must result in a vertex corrected spherical contact lens prescription in the range of -1.00D to -6.00D (inclusive) in each eye.
7. The subject's refractive astigmatism must be less than or equal to -0.75D in both eyes.
8. The subject must have corrective visual acuity of 6/9 (20/30) or better in each eye.
9. The subject must require a visual correction in both eyes (no monofit or monovision allowed).

Exclusion Criteria

1. Any ocular or systemic allergies or diseases that may interfere with contact lens wear.
2. Any systemic disease, autoimmune disease, or use of medication, which may interfere with contact lens wear.
3. Clinically significant (Grade 3 or 4) corneal edema, corneal vascularization, corneal staining, or infiltrates or any other abnormalities of the cornea which would contraindicate contact lens wear.
4. Clinically significant (Grade 3 or 4) tarsal abnormalities or bulbar injection which might interfere with contact lens wear.
5. Any ocular infection.
6. Any corneal distortion resulting from previous hard or rigid gas permeable contact lens wear.
7. Currently pregnant or lactating (subject who become pregnant during the study will be discontinued).
8. Diabetes.
9. Infectious diseases (e.g. hepatitis, tuberculosis) or an immunosuppressive disease (e.g. HIV).
10. Amblyopia
11. Evidence of lid abnormality or infection (including blepharitis/meibomitis)
12. Conjunctival abnormality or infection.
13. Any active ocular disease.
14. Employee or family member of the staff of the investigational site.

Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes